Home

Medicamen Biotech PE Ratio

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

PE

66.9

Last updated on: May 15, 2025

Key Highlights

  • The P/E Ratio of Medicamen Biotech Ltd is 66.9 as of 15 May 9.00 AM .
  • The P/E Ratio of Medicamen Biotech Ltd changed from 16.6 on March 2020 to 44.5 on March 2024 . This represents a CAGR of 21.80% over 5 years.
  • The Latest Trading Price of Medicamen Biotech Ltd is ₹ 442.35 as of 14 May 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.2. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Medicamen Biotech Ltd

No data available

Company Fundamentals for Medicamen Biotech Ltd

Image

Medicamen Biotech Ltd

NSE: MEDICAMEQ

Share Price

₹ 442.35

6.05 (1.39%)

stock direction

Last updated on: May 14, 2025

Market Price of Medicamen Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Medicamen Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 May 2025442.35
13 May 2025436.3
12 May 2025434.65
09 May 2025423.45
08 May 2025425.9
07 May 2025423.55
06 May 2025428.25
05 May 2025445.05
02 May 2025433.25
30 Apr 2025426.25

SWOT Analysis Of Medicamen Biotech Ltd

Strength

4

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Medicamen Biotech Ltd

Asset Value vs Market Value of Medicamen Biotech Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Medicamen Biotech Ltd562.43
Sun Pharmaceutical Industries Ltd409818
Divis Laboratories Ltd164628
Cipla Ltd120775
Torrent Pharmaceuticals Ltd109753
Mankind Pharma Ltd105255

PE Ratio of Medicamen Biotech Ltd Explained

562.43

Market cap

8

Earnings

66.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Medicamen Biotech Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Medicamen Biotech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Medicamen Biotech Ltd

No data available

* All values are in %

About Medicamen Biotech Ltd

  • A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets.
  • The Company has presence in 40+ countries.
  • Its offerings include Finished Dosage Forms (FDF's) to African countries. In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market.
  • MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan).
  • The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others.

Medicamen Biotech Ltd News Hub

Medicamen Biotech consolidated net profit declines 67.70% in the June 2024 quarter

Net profit of Medicamen Biotech declined 67.70% to Rs 1.35 crore in the quarter ended June 2024 as a

Read more

13 Aug 24

Medicamen Biotech to conduct board meeting

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024. Po

Read more

12 Aug 24

Medicamen Biotech to conduct AGM

Medicamen Biotech announced that the Annual General Meeting (AGM) of the company will be held on 26

Read more

13 Sept 24

Medicamen Biotech declare Quarterly Result

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024 P

Read more

08 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Medicamen Biotech Ltd

What is the current PE Ratio of Medicamen Biotech Ltd?

The Current PE Ratio of Medicamen Biotech Ltd is 66.92 as on 15 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 15 May 2025.

What was the PE Ratio of Medicamen Biotech Ltd last year?

The PE Ratio of Medicamen Biotech Ltd was 55.89 last year, now the PE ratio is 66.92, showing a year-on-year growth of 19.7%.

What does the PE Ratio of Medicamen Biotech Ltd indicate about its stock?

The PE Ratio of Medicamen Biotech Ltd is 66.92. This ratio indicates that investors are willing to pay 66.92 times the earnings per share for each share of Medicamen Biotech Ltd.

What is the PE Ratio Growth of Medicamen Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Medicamen Biotech Ltd grew by 19.7% whereas, the EPS ratio grew by 223.9.

How does the PE ratio of Medicamen Biotech Ltd compare to industry peers?

The PE ratio of Medicamen Biotech Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Medicamen Biotech Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Medicamen Biotech Ltd PE Ratio.

What factors influence the PE ratio of Medicamen Biotech Ltd PE Ratio?

The PE ratio of Medicamen Biotech Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Medicamen Biotech Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Medicamen Biotech Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Medicamen Biotech Ltd PE Ratio?

You can check the latest PE ratio of Medicamen Biotech Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Medicamen Biotech Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Medicamen Biotech Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Medicamen Biotech Ltd PE Ratio predict future stock performance?

While the Medicamen Biotech Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions